Application Guidelines for the Taiwan Biotechnology and Pharmaceutical Development Foundation’s “Wu Ho-Su Medical Award” (Application Deadline: October 31, 2026)
Office of Research and Development Notice No. 1150037
October 1, 2026
The Wu Ho-Su Medical Award was established through corporate donations in memory of Taiwanese entrepreneur Mr. Wu Ho-Su. The award aims to encourage innovation and advancement in medical research in Taiwan.
Eligibility
Outstanding scholars under the age of 50 in Taiwan’s biotechnology and biomedical fields who are employed at public or private universities or colleges and continue to conduct medical research.
Award Amounts and Requirements
- A total of NT$6.3 million is awarded annually to three recipients, each receiving NT$2.1 million. Awards may remain unfilled if no suitable candidates are identified.
- Applicants must not have received a major national award for the same research, such as the Presidential Science Prize, Wang Ming-Ning Award, Lee Tien-Te Pharmaceutical Technology Excellence Award, or Y. Z. Hsu Science and Technology Award.
- If the submitted research represents a collaborative achievement, the applicant must be either the first author or an individual who has made a significant contribution. All collaborators must endorse the application and sign the application form. The applicant must also clearly describe the extent and impact of their individual contribution for the review committee’s consideration. If selected, only the applicant will receive the award.
Application Period
Applications are open now through October 31, 2026, as determined by the postmark date.
Further Information
